Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLDEN-505: Elafibranor in NASH
NCT01694849Phase 2Completed
- Sponsor
- Genfit
- Start
- Sep 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of elafibranor in Nonalcoholic steatohepatitis (NASH), sponsored by Genfit. Started Sep 2012; status: completed.
02
Drugs
elafibranor
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01694849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01694849.